FDA approves revised medication guide for Coumadin

The FDA has approved a revised medication guide and labeling for Bristol-Myers Squibb's blood thinner Coumadin (warfarin sodium) to more prominently emphasize a warning about the risk of major or fatal bleeding.
You must be a registered member of MMM to post a comment.

Next Article in Legal/Regulatory